xRead - Nasal Obstruction (September 2024) Full Articles

20426984, 2021, 3, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/alr.22741 by Stanford University, Wiley Online Library on [01/07/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

349

Orlandi et al.

(Continues)

correlate with MCP-1,

RANTES, and bFGF in

CRSsNP. Serum 25VD3

higher in CRSsNP than controls. Mulligan 719 2014 4 Case-Control 21 Control (CSF

No difference in serum 25VD3 level between CRSsNP and controls.

No difference in serum 25VD3 between CRSsNP and controls.

No difference in 25VD3 between CRSsNP and

controls. No difference in serum calcium between

groups. Phosphate is higher in Controls and CRSsNP

when compared to AFRS and CRSwNP patients. Sansoni 726 2015 4 Case-control 12Control 31CRSsNP Serum 25VD3

sinonasal 25VD3 between CRSsNP and controls.

Sinonasal 25VD3 to 1,25VD3 conversion Cigarette Smoke associated with lower 25VD3 levels. Wang 720 2013 4 Case-Control 25CRSwNP 20CRSsNP Serum 25VD3 Polyp grade

Study Year LOE Study Design Study Groups Clinical Endpoint Conclusions Mostafa 716 2016 4 Case-control 19Control 25AFRS Serum 25VD3

Serum 25VD3 did not

No difference in serum or

Number of CD209 + Dendritic

Sinonasal MCP-1, RANTES, and bFGF levels

cells in nasal biopsy/high powered field

Serum and sinonasal 25VD3 Sinonasal CYP27B1 gene expression

Lund-Mackay Score Total IgE Serum 25VD3

Serum Calcium

Serum Phosphate

leak/pituitary tumor patients) 40CRSsNP 45CRSwNP

14Control

17CRSsNP

5CRSwNP 14AFRS

15CRSwNP

15CRSsNP

Case-Control

Mulligan 717 2012 4 Retrospective

TABLE IX-8 (Continued)